Literature DB >> 9570574

A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese.

T Horiuchi1, H Nishizaka, T Kojima, T Sawabe, Y Niho, P M Schneider, S Inaba, K Sakai, K Hayashi, C Hashimura, Y Fukumori.   

Abstract

Deficiency of the ninth component of complement (C9D) is one of the most common genetic abnormalities in Japan, with an incidence of one homozygote in 1000. Although C9D individuals are usually healthy, it has been shown that they have an significantly increased risk of developing meningococcal meningitis. In the present study we report the molecular bases for C9D in 10 unrelated Japanese subjects. As a screening step for mutations, exons 2 to 11 of the C9 gene were analyzed using exon-specific PCR/single-strand conformation polymorphism analysis, which demonstrated aberrantly migrating DNA bands in exon 4 in all the C9D subjects. Subsequent direct sequencing of exon 4 of the C9D subjects revealed that eight of the 10 C9D subjects were homozygous for a C to T transition at nucleotide 343, the first nucleotide of the codon CGA for Arg95, leading to a TGA stop codon (R95X). R95X is a novel mutation different from those recently identified in a Swiss family with C9D. Cases 6 and 7 were heterozygous for the R95X mutation. Family study in case 10 confirmed the genetic nature of the defect. In case 6, the second mutation for C9D of the C9 gene was identified to be the substitution of Cys to Tyr at amino acid residue 507 (C507Y), while the genetic defect(s) in the other allele in case 7 remains unknown. Our results indicate that a novel mutation, R95X, is present in most cases of C9D in Japan.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570574

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Founder effect of the C9 R95X mutation in Orientals.

Authors:  Vahid Khajoee; Kenji Ihara; Ryutaro Kira; Megumi Takemoto; Hiroyuki Torisu; Yasunari Sakai; Jia Guanjun; Park Myoung Hee; Katsushi Tokunaga; Toshiro Hara
Journal:  Hum Genet       Date:  2003-01-09       Impact factor: 4.132

3.  The rare C9 P167S risk variant for age-related macular degeneration increases polymerization of the terminal component of the complement cascade.

Authors:  O McMahon; T M Hallam; S Patel; C L Harris; A Menny; W M Zelek; R Widjajahakim; A Java; T E Cox; N Tzoumas; D H W Steel; V G Shuttleworth; K Smith-Jackson; V Brocklebank; H Griffiths; A J Cree; J P Atkinson; A J Lotery; D Bubeck; B P Morgan; K J Marchbank; J M Seddon; D Kavanagh
Journal:  Hum Mol Genet       Date:  2021-06-17       Impact factor: 5.121

4.  Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia.

Authors:  Moonhee Lee; Sujaatha Narayanan; Edith G McGeer; Patrick L McGeer
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 5.  The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.

Authors:  Maartje J Geerlings; Eiko K de Jong; Anneke I den Hollander
Journal:  Mol Immunol       Date:  2016-12-06       Impact factor: 4.407

Review 6.  Monogenic Adult-Onset Inborn Errors of Immunity.

Authors:  Frederik Staels; Tom Collignon; Albrecht Betrains; Margaux Gerbaux; Mathijs Willemsen; Stephanie Humblet-Baron; Adrian Liston; Steven Vanderschueren; Rik Schrijvers
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

Review 7.  Molecular Genetic Mechanisms in Age-Related Macular Degeneration.

Authors:  Aumer Shughoury; Duriye Damla Sevgi; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2022-07-12       Impact factor: 4.141

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.